Affinity Asset Advisors LLC increased its position in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 8.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 452,821 shares of the company’s stock after acquiring an additional 35,323 shares during the quarter. Verona […]
Affinity Asset Advisors LLC boosted its holdings in Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) by 50.4% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 751,796 shares of the company’s stock after purchasing an additional 251,796 shares during the quarter. Inozyme […]
Affinity Asset Advisors LLC raised its position in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 8.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 452,821 shares of the company’s stock after purchasing an additional 35,323 shares during the quarter. Verona Pharma makes up approximately […]
Canaccord Genuity Group reaffirmed their buy rating on shares of Verona Pharma (NASDAQ:VRNA – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $35.00 target price on the stock. A number of other equities research analysts have also recently commented on VRNA. 500.com reaffirmed a reiterates rating on […]
StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 1.7 % Shares of NASDAQ EVOK opened at $1.22 on Wednesday. The company has a quick ratio […]